Komori
Semiannual Securities Report4524MORISHITA JINTAN CO.,LTD.Pharmaceuticals

Semiannual Securities Report — FY2026 H1

What MORISHITA JINTAN CO.,LTD. reported for the period from 2026-04-01 to 2027-03-31.

Filed 2026-11-11View the original on EDINET
How much it says
44Thin
What moved here
7named for the first time
Its own wording
25terms
Which filing this is
37/ 37newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

During the interim consolidated accounting period, the Company recorded revenue of ¥6,665 million and operating profit of ¥627 million, among other results. In the Consumer Business, it is seeking higher earnings through more efficient promotional activities for Tansa fatty acid, while in the Solutions Business it is strengthening the production structure for seamless capsule contract manufacturing by constructing a new capsule manufacturing line, scheduled for completion in the second half of 2027. The filing refers to geopolitical risks, including the situation in the Middle East, but states that there have been no new material business or other risks or material changes.

Komori's summary of this document, not the document's own words.
44Thin
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 36 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
Magnitude of Change
38
Thin
Strategic Shift
52
Typical
Capital Movement
62
Detailed
Disclosure Gaps
0
Almost nothing
Concentration Risk
68
Detailed
Change in Risk
37
Thin
Financial and Capital Policy
31
Thin
Disclosure Specificity
7
Almost nothing
Product Portfolio
55
Typical
Technology Position
50
Typical
Conviction Behind Strategic Bets
R&D spend6億円Money spent making new things.
Cash left over-5億円Cash from the business, less what went into equipment.
Spent on equipment11億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
MORISHITA JINTAN CO.,LTD. — FY2026 H1 | Komori